Treatment-naïve high risk chronic lymphocytic leukemia Clinical Trials
Conditions / Treatment-naïve high risk chronic lymphocytic leukemia
Delta Trials records 1 clinical trial for Treatment-naïve high risk chronic lymphocytic leukemia in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 76 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
1
Total Trials
0
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
76
Study Locations
Browse by location (76 total)
- Paris, France 1 trialAll trials in Paris, France
- Leuven, Belgium 1 trialAll trials in Leuven, Belgium
- Petah Tikva, Israel 1 trialAll trials in Petah Tikva, Israel
- Pessac, France 1 trialAll trials in Pessac, France
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States
- Milan, Italy 1 trialAll trials in Milan, Italy
- Brescia, Italy 1 trialAll trials in Brescia, Italy
- Ramat Gan, Israel 1 trialAll trials in Ramat Gan, Israel
- Madrid, Spain 1 trialAll trials in Madrid, Spain
- Boston, United States 1 trialAll trials in Boston, United States
- Lake Success, United States 1 trialAll trials in Lake Success, United States
- Nantes, France 1 trialAll trials in Nantes, France
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium
- Tel Aviv, Israel 1 trialAll trials in Tel Aviv, Israel
- Copenhagen, Denmark 1 trialAll trials in Copenhagen, Denmark
- Kraków, Poland 1 trialAll trials in Kraków, Poland
- Durham, United States 1 trialAll trials in Durham, United States
- Hackensack, United States 1 trialAll trials in Hackensack, United States
- Bologna, Italy 1 trialAll trials in Bologna, Italy
- Meldola, Italy 1 trialAll trials in Meldola, Italy